Use of a Tumor-Cell Enrichment Column for the Enhanced Detection of Minimal Residual Disease in the BM or Apheresis Peripheral Blood Transplant Products of Breast-Cancer Patients

By Shammo JM   Smith SL   Bennett MV   Lee HW   Ostrander A   Ross AA   Williams SF  

Cytotherapy, Vol. 1, Iss. 5, 1999-01 ,pp. : 367-376

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Combination of high-dose chemotherapy and monoclonal antibody in breast-cancer patients: a pilot trial to monitor treatment effects on disseminated tumor cells

By Hempel D.   Müller P.   Oruzio D.   Behr W.   Brockmeyer C.   Wochner M.   Ehnle S.   Riethmüller G.   Schlimok G.  

Cytotherapy, Vol. 2, Iss. 4, 2000-04 ,pp. : 287-296

Ashgate Publishing Ltd

Access to resources Recommend Favorite

BM micrometastases and circulating tumor cells in breast cancer patients: where have we been, where are we now and where does the future lie?

By Müller V   Pantel K  

Cytotherapy, Vol. 7, Iss. 6, 2005-12 ,pp. : 478-482

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Detection of isolated tumor cells in peripheral blood and in BM: evaluation of a new enrichment method

By Naume B   Borgen E   Tøssvik S   Pavlak N   Oates D   Nesland Jm  

Cytotherapy, Vol. 6, Iss. 3, 2004-06 ,pp. : 244-252

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Immunological properties of mononuclear cells from blood stem cell harvests following mobilization with erythropoietin + G-CSF in cancer patients

By Joshi S.   Miller K.   Jackson J.D.   Warkentin P.   Kessinger A.  

Cytotherapy, Vol. 2, Iss. 1, 2000-01 ,pp. : 15-24

Ashgate Publishing Ltd

Access to resources Recommend Favorite